Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity          
Cumulative effect due to adoption of new accounting standard, net of tax $ 64     $ 64  
Balance (in shares) at Dec. 31, 2017 19,511,276 19,511,276      
Beginning Balance at Dec. 31, 2017 $ 20,648 $ 20 $ 88,447 (67,812) $ (7)
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   621,263      
Stock-based compensation 4,096   4,096    
Sales of common stock, net of offering costs (in shares)   6,571,428      
Sales of common stock, net of offering costs 21,190 $ 7 21,183    
Exercise of warrants (in warrants)   89,142      
Exercise of warrants $ 260   260    
Common stock issued in exchange for warrants (in shares) 242,913        
Exercise of stock options (in shares)   4,692      
Exercise of stock options $ 14   14    
Net loss (17,943)     (17,943)  
Foreign currency translation adjustment, net of tax $ 5       5
Balance (in shares) at Sep. 30, 2018 27,040,714 27,040,714      
Ending Balance at Sep. 30, 2018 $ 28,324 $ 27 $ 114,000 $ (85,691) $ (12)